288 results on '"Sugai, Takuro"'
Search Results
2. Prevalence of underweight in patients with schizophrenia: A meta-analysis
3. Effects of nutritional education on weight change and metabolic abnormalities among patients with schizophrenia in Japan: A randomized controlled trial
4. Lower Prolactin Levels in Patients Treated With Aripiprazole Regardless of Antipsychotic Monopharmacy or Polypharmacy
5. Difference in prevalence of metabolic syndrome between Japanese outpatients and inpatients with schizophrenia: A nationwide survey
6. Rare truncating variations and risk of schizophrenia: Whole-exome sequencing in three families with affected siblings and a three-stage follow-up study in a Japanese population
7. A case report of psychiatric symptoms following direct-acting antiviral and ribavirin combination therapy for chronic hepatitis C in a patient with innate anxiety
8. Association Between the Number of Remaining Teeth and Body Mass Index in Japanese Inpatients with Schizophrenia
9. High-density lipoprotein-cholesterol and antipsychotic medication in overweight inpatients with schizophrenia: post-hoc analysis of a Japanese nationwide survey
10. Associations between the number of antipsychotics prescribed and metabolic parameters in Japanese patients with schizophrenia
11. Differences in plasma prolactin levels in patients with schizophrenia treated on monotherapy with five second-generation antipsychotics
12. Association Between the Number of Remaining Teeth and Body Mass Index in Japanese Inpatients with Schizophrenia
13. Sex Differences in the Effect of Atomoxetine on the QT Interval in Adult Patients With Attention-Deficit Hyperactivity Disorder
14. Influence of Atomoxetine on Relationship Between ADHD Symptoms and Prefrontal Cortex Activity During Task Execution in Adult Patients
15. The dopamine D3 receptor ( DRD3) gene and risk of schizophrenia: Case–control studies and an updated meta-analysis
16. Gender differences in the relationship between the risperidone metabolism and the plasma prolactin levels in psychiatric patients
17. Effect of Antipsychotic Polypharmacy On Obesity, Hypertension, Dyslipidemia, and Diabetes
18. Perceived parenting before adolescence and parity have direct and indirect effects via depression and anxiety on maternal–infant bonding in the perinatal period
19. Factor Structure and Measurement Invariance of the Hospital Anxiety and Depression Scale Across the Peripartum Period Among Pregnant Japanese Women
20. Depression, Anxiety and Primiparity are Negatively Associated with Mother–Infant Bonding in Japanese Mothers
21. Changes in PR and QTc intervals after switching from olanzapine to risperidone in patients with stable schizophrenia
22. High prevalence of underweight and undernutrition in Japanese inpatients with schizophrenia
23. Exclusive Breastfeeding Is Not Associated with Maternal–Infant Bonding in Early Postpartum, Considering Depression, Anxiety, and Parity
24. Predictive Utility of Body Mass Index for Metabolic Syndrome Among Patients with Schizophrenia in Japan
25. List of Contributors
26. Pharmacogenomics in Psychiatric Disorders
27. Factor Structure and Measurement Invariance of the Hospital Anxiety and Depression Scale Across the Peripartum Period Among Pregnant Japanese Women
28. Sex differences in the effect of four second-generation antipsychotics on QTc interval in patients with schizophrenia
29. Low prevalence of metabolic syndrome and its prediction in Japanese inpatients with schizophrenia
30. Manic symptoms associated with pregabalin in a patient with conversion disorder
31. Changes in QT interval after switching to quetiapine in Japanese patients with schizophrenia
32. Quetiapine-induced insulin resistance after switching from blonanserin despite a loss in both bodyweight and waist circumference
33. Improvement in quetiapine-induced hypoglycemia following a switch to blonanserin
34. Improvement in QTc prolongation induced by zotepine following a switch to perospirone
35. Six-year complete remission in a patient with disorganized schizophrenia during maintenance electroconvulsive therapy without antipsychotic medication
36. Effect of the cytochrome P450 2D6*10 allele on risperidone metabolism in Japanese psychiatric patients
37. QT prolongation of the antipsychotic risperidone is predominantly related to its 9-hydroxy metabolite paliperidone
38. Dose-dependent effects of olanzapine on QT intervals and plasma prolactin levels in Japanese patients with stable schizophrenia
39. Dose-dependent increase in the QTc interval in aripiprazole treatment after risperidone
40. The relationship between schizophrenia patients' attitudes towards physical health and the prevalence of metabolic syndrome
41. Association of selected antipsychotics on the triglyceride levels in patients with schizophrenia in inpatient and outpatient settings
42. Differences in clinical effect and tolerance between fluvoxamine and paroxetine: A switching study in patients with depression
43. Increase in the risk of chlorpromazine-induced QT prolongation during nighttime: Is a short-period ECG during daytime sufficient?
44. The wide variability of perospirone metabolism and the effect of perospirone on prolactin in psychiatric patients
45. Lower Prolactin Levels in Patients Treated With Aripiprazole Regardless of Antipsychotic Monopharmacy or Polypharmacy
46. Gender differences in prolactin elevation induced by olanzapine in Japanese drug-naïve schizophrenic patients
47. The lowest effective plasma concentration of atomoxetine in pediatric patients with attention deficit/hyperactivity disorder: A non-randomized prospective interventional study.
48. Identifying the factor structure of the Mother‐to‐Infant Bonding Scale for post‐partum women and examining its consistency during pregnancy
49. Non-Linear Pharmacokinetics of Atomoxetine in Adult Japanese Patients With ADHD.
50. Effects of olanzapine on resting heart rate in Japanese patients with schizophrenia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.